Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-δ2-valproic acid in rabbits

Drug Metabolism and Disposition

Volumn 25, Issue 12, 1997, Pages 1337-1346

  Scism, Jamie L ^b   Powers, Karen M ^b   Artru, Alan A ^b   Chambers, Anne C ^b   Lewis, Lydia ^b   Adkison, Kimberly K ^b   Kalhorn, Thomas F ^b   Shen, Danny D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROBENECID; VALPROIC ACID;

ARTICLE; BLOOD BRAIN BARRIER; CELL MEMBRANE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; COMPARTMENT MODEL; DRUG EFFECT; LIVER TOXICITY; PRIORITY JOURNAL; RABBIT; STEADY STATE; TISSUE DISTRIBUTION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CEREBRAL VENTRICLES; CISTERNA MAGNA; DRUG INTERACTIONS; FATTY ACIDS, MONOUNSATURATED; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; KINETICS; MALE; PERFUSION; PROBENECID; RABBITS; TISSUE DISTRIBUTION;

EID: 0031466148     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. T. Kondo, S. Kaneko, K. Otani, M. Ishida, T. Hirano, Y. Fukushima, H. Muranaka, N. Koide, and M. Yokoyama: Associations between risk factors for valproate hepatotoxicity and altered valproate metabolism. Epilepsia 33, 172-177 (1992).
2. S. A. Konig, H. Siemes, F. Boenigk, G. Gross-Selbeck, F. Hanefeld, N. Haas, B. Kohler, W. Koelfen, R. Korinthenberg, E. Kurek, H.-G. Lenard, H. Penin, J. M. Penizen, W. Schunke, C. Schultze, U. Stephani, M. Stute, M. Traus, H.-M. Weinmann, and D. Scheffner: Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. Epilepsia 35, 1005-1015 (1994).
3. A. E. Bryant III and F. E. Dreifuss: Valproic acid hepatic fatalities. III. U.S. experience since 1986. Neurology 46, 465-469 (1996).
4. H. Nau, R.-S. Hauck, and K. Ehlers: Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacol. Toxicol. 69, 310-321 (1991).
5. D. Cotariu and J. L. Zaidman: Developmental toxicity of valproic acid. Life Sci. (Washington, D.C.) 48, 1341-1350 (1991).
6. H. Nau and W. Loscher: Valproic acid and metabolites: pharmacological and toxicological studies. Epilepsia 25, (Suppl. 1) S14-S22 (1984).
7. W. Loscher, U. Wahnschaffe, D. Honack, W. Wittfoht, and H. Nau: Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver: I. biochemical, histological and pharmacokinetic studies. Epilepsy Res. 13, 187-198 (1992).
8. W. Loscher, H. Nau, U. Wahnschaffe, D. Honack, C. Rundfeldt, W. Wittfoht, and U. Bojie: Effects of valproic acid and E-2-en-valproate on functional and morphological parameters of rat liver: II. influence of phenobarbital comedication. Epilepsy Res. 15, 113-131 (1993).
9. K. Ehlers, H. Sturje, H.-J. Merker, and H. Nau: The valproic acid metabolite E-2-n-propyl-2-pentenoic acid does not induce spina bifida in the mouse. Dev. Pharmacol. Ther. 19, 196-204 (1992).
10. J. E. Fisher, Jr., K. D. Acuff-Smith, M. A. Schilling, H. Nau, and C. V. Vorhees: Trans-2-ene-valproic acid is less behaviorally teratogenic than an equivalent dose of valproic acid in rats. Teratology 49, 479-486 (1984).
11. 2(E)-valproate) in healthy male volunteers. Pharm. Weekbl. 14, 152-158 (1992).
12. F. J. E. Vajda, G. A. Donnan, J. Phillips, and P. F. Bladin: Human brain, plasma and cerebrospinal fluid concentration of sodium valproate after 72 hr of therapy. Neurology 31, 486-487 (1981).
13. H. G. Wieser: Comparison of valproate concentrations in human plasma, CSF and brain tissue after administration of different formulations of valproate or valpromide. Epilepsy Res. 9, 154-159 (1991).
14. D. D. Shen, G. A. Ojemann, R. L. Rapport, R. L. Dills, P. N. Friel, and R. H. Levy: Low and variable presence of valproic acid in human brain. Neurology 42, 582-585 (1992).
15. K. D. K. Adkison, G. A. Ojemann, R. L. Rapport, R. L. Dills, and D. D. Shen: Distribution of unsaturated metabolites of valproate in human and rat brain: pharmacological relevance? Epilepsia 36, 772-782 (1995).
16. R. H. Levy: CSF and plasma pharmacokinetics: relationship to mechanisms of action as exemplified by valproic acid in monkey. In "Epilepsy: A Window to Brain Mechanisms" (J. S. Lockard and A. A. Ward, eds.), pp. 191-200. Raven Press, New York, 1980.
17. W. Loscher and H. Nau: Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment. J. Pharmacol. Exp. Ther. 226, 845-854 (1983).
18. K. D. K. Adkison and D. D. Shen: Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter. J. Pharmacol. Exp. Ther. 276, 1189-1200 (1996).
19. K. Naora and D. D. Shen: Mechanism of valproic acid uptake by isolated rat brain microvessels. Epilepsy Res. 22, 97-106 (1995).
20. K. D. K. Adkison, A. A. Artru, K. M. Powers, and D. D. Shen: Contribution of probenecid-sensitive anion transport processes at the brain capillary endothelium and choroid plexus to the efficient efflux of valproic acid from the central nervous system. J. Pharmacol. Exp. Ther. 268, 797-805 (1994).
21. M. Pollay and H. Davson: The passage of certain substances out of the cerebrospinal fluid. Brain 86, 137-150 (1963).
22. A. W. Rettenmeier, W. N. Howald, R. H. Levy, D. J. Witek, W. P. Gordon, D. J. Porubek, and T. A. Baillie: Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic/mass spectrometric techniques. Biomed. Environ. Mass Spectrom. 18, 192-199 (1989).
23. J. C. Foxworthy and A. A. Artru: Cerebrospinal fluid dynamics and brain tissue composition following i.v. infusion of hypertonic saline in anesthetized rabbits. J. Neurosurg. Anesthesiol. 2, 256-265 (1990).
24. T. K. Gregory, and D. C. Pettus: An electroencephalographic processing algorithm specifically intended for analysis of cerebral electrical activity. J. Clin. Monit. 2, 190-197 (1986).
25. N. T. Smith, C. J. Westover, Jr., M. Quinn, J. L. Benthuysen, H. D. Silver, and T. J. Sanford, Jr.: An electroencephalographic comparison of alfentanil with other narcotics and with thiopental. J. Clin. Monit. 1, 236-244 (1985).
26. K. D. K. Adkison, A. A. Arthur, K. M. Powers, D. Nochlin, and D. D. Shen: Role of choroid plexus epithelium in the removal of valproic acid from the central nervous system. Epilepsy Res. 20, 185-192 (1995).
27. K. D. K. Adkison, K. M. Powers, A. A. Artru, and D. D. Shen: Effect of para-aminohippurate on the efflux of valproic acid from the central nervous system of the rabbit. Epilepsy Res. 23, 95-104 (1996).
28. H. Davson: Chemical composition and secretory nature of fluids. In "Physiology of the Cerebrospinal Fluid" (H. Davson, J. Landers, and A. Churchill, eds.), pp. 33-54. J. and A., Churchill, London, 1970.
29. R. L. O. Semmes and D. D. Shen: Capillary gas chromatographic assay for valproic acid and its 2-desaturated metabolite in brain and plasma. J. Chromatogr. 432, 185-197 (1988).
30. S. R. Heisey, D. Held, and J. R. Pappenheimer: Bulk flow and diffusion in the cerebrospinal fluid system of the goat. Am. J. Physiol. 203, 775-781 (1962).
31. J. Kuo, E. Fox, and S. McDonald: Comparing two or more groups. In "SigmaStat User's Manual" (J. Kuo, E. Fox, and S. McDonald, eds.), pp. 6-12 to 6-80. Jandel Scientific, San Rafael, 1992.
32. R. Spector and A. V. Lorenzo: The effects of salicylate and probenecid on the cerebrospinal fluid transport of penicillin, aminosalicylic acid and iodide. J. Pharmacol. Exp. Ther. 188, 55-65 (1974).
33. W. M. Pardridge: Brain metabolism: a perspective from the blood-brain barrier. Physiol. Rev. 63, 1481-1535 (1983).
34. J. L. Meek and N. H. Neff: Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain? Neuropharmacology 12, 497-499 (1973).
35. M. Bradbury: "The Concept of a Blood-Brain Barrier." John Wiley & Sons, New York, 1979.
36. J. L. Scism, K. M. Powers, A. A. Artru, and D. D. Shen: The effect of probenecid on extracellular and intracellular compartmentation of valproic acid in the rabbit brain as determined by microdialysis. Pharm. Res. 13, S456 (1996).
37. M. Nilson, E. Hanson, and L. Ronnback: Transport of valproate and its effects on GABA uptake in astroglial primary culture. Neurochem. Res. 15, 763-767 (1990).